Evidence map›Paper›PMID 36203169›Full record

ArticleTrials2022

Examining evidence of time-dependent treatment effects: an illustration using regression methods.

Kim M Jachno, Stephane Heritier, Robyn L Woods, Suzanne Mahady, Andrew Chan, Andrew Tonkin, Anne Murray, John J McNeil, Rory Wolfe

Open access · goldAbstract read
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Balloon dilatation is superior to COEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Kim M JachnoPublic Health and Preventive Medicine, Monash University, Melbourne, Australia. kim.jachno@monash.edu.ORCID http://orcid.org/0000-0003-2550-9674
Stephane HeritierPublic Health and Preventive Medicine, Monash University, Melbourne, Australia.
Robyn L WoodsPublic Health and Preventive Medicine, Monash University, Melbourne, Australia.
Suzanne MahadyPublic Health and Preventive Medicine, Monash University, Melbourne, Australia.
Andrew ChanClinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA.
Andrew TonkinPublic Health and Preventive Medicine, Monash University, Melbourne, Australia.
Anne MurrayBerman Centre for Outcomes and Clinical Research, Hennepin Health Research Institute, Minneapolis, MN, USA.
John J McNeilPublic Health and Preventive Medicine, Monash University, Melbourne, Australia.
Rory WolfePublic Health and Preventive Medicine, Monash University, Melbourne, Australia.
Monash University · AUMassachusetts General Hospital · USMonash Health · AUUniversity of Minnesota · US

Funding

ASPirin in Reducing Events in the ElderlyU01AG029824 · NIA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI MCNEIL, JOHN JAMES, MURRAY, ANNE M · 2009 to 2018
$64.6M
Main Administrative CoreU19AG062682 · NIA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI CHAN, ANDREW T, MCNEIL, JOHN JAMES · 2019 to 2023
$42.9M
Precision Prevention Research ProgramR35CA253185 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Andrew T Chan · 2020 to 2026
$6.9M
GYNECOLOGIC ONCOLOGY GROUPR03CA062682 · NCI · AMERICAN COLLEGE OF OB AND GYN · PI PARK, ROBERT C · 1995 to 1996
–
NCI NIH HHS R35 CA253185NCI NIH HHS U19AG062682NIA NIH HHS U01 AG029824NIA NIH HHS U01AG029824NIA NIH HHS U19 AG062682
6 · The paper itself

Abstract

backgroundFor the design and analysis of clinical trials with time-to-event outcomes, the Cox proportional hazards model and the logrank test have been the cornerstone methods for many decades. Increasingly, the key assumption of proportionality-or time-fixed effects-that underpins these methods has been called into question. The availability of novel therapies with new mechanisms of action and clinical trials of longer duration mean that non-proportional hazards are now more frequently encountered.

methodsWe compared several regression-based methods to model time-dependent treatment effects. For illustration purposes, we used selected endpoints from a large, community-based clinical trial of low dose daily aspirin in older persons. Relative and absolute estimands were defined, and analyses were conducted in all participants. Additional exploratory analyses were undertaken by selected subgroups of interest using interaction terms in the regression models. DISCUSSION: In the trial with median 4.7 years follow-up, we found evidence for non-proportionality and a time-dependent treatment effect of aspirin on cancer mortality not previously reported in trial findings. We also found some evidence of time-dependence to an aspirin by age interaction for major adverse cardiovascular events. For other endpoints, time-fixed treatment effect estimates were confirmed as appropriate.

conclusionsThe consideration of treatment effects using both absolute and relative estimands enhanced clinical insights into potential dynamic treatment effects. We recommend these analytical approaches as an adjunct to primary analyses to fully explore findings from clinical trials.

Indexed as

AspirinAgedAged, 80 and overHumansProportional Hazards ModelsTime FactorsAspirinClinical trialsFlexible parametric modellingProportional hazardsTime-dependent effectsTreatment effect heterogeneity

Identifiers

PMID36203169
PMCPMC9535854
OpenAlexW4302299563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.